Helix BioPharma Corp (HBPCF)
0.1377
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Helix BioPharma Cash from Operations (TTM): -4.436M for Oct. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
October 31, 2023 | -4.436M |
July 31, 2023 | -4.117M |
April 30, 2023 | -4.366M |
January 31, 2023 | -4.544M |
October 31, 2022 | -4.823M |
July 31, 2022 | -5.126M |
April 30, 2022 | -5.026M |
January 31, 2022 | -5.300M |
October 31, 2021 | -6.569M |
July 31, 2021 | -7.302M |
April 30, 2021 | -7.503M |
January 31, 2021 | -7.381M |
October 31, 2020 | -6.638M |
July 31, 2020 | -8.051M |
April 30, 2020 | -7.454M |
January 31, 2020 | -6.905M |
October 31, 2019 | -7.100M |
July 31, 2019 | -4.189M |
April 30, 2019 | -4.803M |
January 31, 2019 | -4.938M |
October 31, 2018 | -4.786M |
July 31, 2018 | -5.904M |
April 30, 2018 | -6.650M |
January 31, 2018 | -6.856M |
October 31, 2017 | -7.066M |
Date | Value |
---|---|
July 31, 2017 | -7.018M |
April 30, 2017 | -6.888M |
January 31, 2017 | -7.016M |
October 31, 2016 | -6.974M |
July 31, 2016 | -6.668M |
April 30, 2016 | -6.738M |
January 31, 2016 | -6.648M |
October 31, 2015 | -6.544M |
July 31, 2015 | -7.146M |
April 30, 2015 | -6.335M |
January 31, 2015 | -6.329M |
October 31, 2014 | -7.168M |
July 31, 2014 | -7.173M |
April 30, 2014 | -7.947M |
January 31, 2014 | -8.147M |
October 31, 2013 | -7.551M |
July 31, 2013 | -7.763M |
April 30, 2013 | -6.823M |
January 31, 2013 | -11.89M |
October 31, 2012 | -16.19M |
July 31, 2012 | -15.41M |
April 30, 2012 | -17.77M |
January 31, 2012 | -14.10M |
October 31, 2011 | -8.798M |
July 31, 2011 | -10.40M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-8.051M
Minimum
Jul 2020
-4.117M
Maximum
Jul 2023
-5.935M
Average
-5.934M
Median
Cash from Operations (TTM) Benchmarks
Acasti Pharma Inc | -13.57M |
Aurinia Pharmaceuticals Inc | -33.46M |
Edesa Biotech Inc | -6.252M |
Lexaria Bioscience Corp | -5.209M |
Xenon Pharmaceuticals Inc | -145.33M |